Results 1 to 10 of about 33,030 (228)

Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes [PDF]

open access: yesPharmaceuticals, 2021
Ubiquitination represents a post-translational modification (PTM) essential for the maintenance of cellular homeostasis. Ubiquitination is involved in the regulation of protein function, localization and turnover through the attachment of a ubiquitin ...
Paula Soares, Correia M, Soares Paula
exaly   +8 more sources

Roles of ubiquitin-specific proteases in inflammatory diseases [PDF]

open access: yesFrontiers in Immunology
Ubiquitin-specific proteases (USPs), as one of the deubiquitinating enzymes (DUBs) families, regulate the fate of proteins and signaling pathway transduction by removing ubiquitin chains from the target proteins.
Yanjun Liu, Wang Mengyuan, Linke Li
exaly   +6 more sources

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619 [PDF]

open access: yesCells, 2021
Osteosarcoma (OS) is the most common malignant bone tumor in children and teenagers. In many cases, such as poor response to treatment or the presence of metastases at diagnosis, the survival rate of patients remains very low. Although in the literature,
Benjamin Ory   +2 more
exaly   +4 more sources

Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy [PDF]

open access: yesFrontiers in Pharmacology, 2018
Dysfunction or dysregulation of the ubiquitin proteasome system (UPS) is closely related to tumorigenesis and the development of multiple cancers. Targeting the UPS provides a new anticancer therapeutic strategy, but clinically available UPS-targeted ...
Qiaojun He, Hong Zhu, Xuejing Shao
exaly   +4 more sources

Ubiquitin-specific proteases (USPs) in leukemia: a systematic review [PDF]

open access: yesBMC Cancer
Background Leukemia, a type of blood cell cancer, is categorized by the type of white blood cells affected (lymphocytes or myeloid cells) and disease progression (acute or chronic).
Alireza Zangooie   +9 more
doaj   +4 more sources

Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models [PDF]

open access: yesBiomedicines, 2023
Background: The inhibition of ubiquitin-specific proteases (USPs) is a novel and promising direction in the development of molecularly targeted therapies in oncology.
Tomasz Szydełko   +2 more
exaly   +4 more sources

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application [PDF]

open access: yesJournal of Experimental & Clinical Cancer Research, 2023
Tumors have evolved in various mechanisms to evade the immune system, hindering the antitumor immune response and facilitating tumor progression. Immunotherapy has become a potential treatment strategy specific to different cancer types by utilizing ...
Hongli Gao   +8 more
doaj   +2 more sources

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation [PDF]

open access: yesCell Death and Disease, 2022
The exact pathogenesis of inflammatory bowel disease (IBD), a chronic gastrointestinal inflammatory disease comprising Crohn’s disease and ulcerative colitis, remains unclear.
Rirong Chen   +5 more
doaj   +2 more sources

Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets [PDF]

open access: yesPeerJ
Lung cancer ranks as the leading cause of cancer-related mortality worldwide, characterised by complex molecular mechanisms and high therapeutic resistance.
Xiaoyun Shen   +7 more
doaj   +3 more sources

Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction [PDF]

open access: yesFrontiers in Oncology, 2022
Regulation of ubiquitination is associated with multiple processes of tumorigenesis and development, including regulation of the tumor immune microenvironment.
Jinhui Guo   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy